Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-02-20 @ 8:25 PM
Study NCT ID:
NCT03301168
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-07-12
First Post:
2017-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Sponsor:
Bellicum Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Lymphoblastic Leukemia | View |
| None | Leukemia, Acute Myeloid (AML), Child | View |
| None | Lymphoma, Non-Hodgkin | View |
| None | Myelodysplastic Syndromes | View |
| None | Primary Immune Deficiency Disorder | View |
| None | Osteopetrosis | View |
| None | Cytopenia | View |
| None | Hemoglobinopathy in Children | View |
| None | Anemia, Aplastic | View |